Marksans Pharma raises Rs 372.40 crore in equity via conversion of warrants issued to OrbiMed and… EP News Bureau Jan 20, 2023 The warrants are converted at a price of Rs 74 per share, reflecting the promoter's and OrbiMed's commitment to the company
Valneva secures new financing with Deerfield and OrbiMed Reuters Apr 27, 2022 Valneva said it had agreed to increase the principal amount of its existing $60 million debt financing agreement with up to an…
